Same Indication

Nivolumab vs Valproic Acid

Nivolumab vs Valproic Acid: Overview

This comparison examines the pharmacological differences between Nivolumab and Valproic Acid.

Mechanism of Action

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Valproic Acid: Enhances GABA transmission and blocks sodium/calcium channels.

Pharmacokinetics

Half-life: Nivolumab — 27 days; Valproic Acid — 9-16 hours.

Chemical Properties

Molecular Formula: Valproic Acid — C8H16O2.

Molecular Weight: Valproic Acid — 144.2110 g/mol.

Type: Nivolumab — Antibody; Valproic Acid — Small molecule.